Declare Dapagliflozin Evaluation of Cardiovascular Events Trademark Details

This mark is dead with a status of Abandoned - No Statement of Use Filed. The last case file activity for this mark occured 9 years ago on Monday, September 22, 2014, according to the United State Patent & Trademark Office
Word Mark Declare Dapagliflozin Evaluation of Cardiovascular Events
Status Dead 606 — Abandoned - No Statement of Use Filed
Serial Number 85525585
Status Date Monday, September 22, 2014
Filing Date Monday, September 22, 2014
Attorney Marc Stanislawczyk

Correspondent

Marc Stanislawczyk
AstraZeneca Pharmaceuticals LLP
FOP3-022
1800 Concord Pike
Wilmington DE 19850-5437

Case File Statements

Disclaimer with Predetermined Text "Dapagliflozin Evaluation of Cardiovascular Events"
Goods & Services Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use for pharmaceutical research and development

Classifications

International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 6 — Active
Status Date Monday, January 30, 2012
Primary Code 042

You must be signed in to print.

Once signed in, look for the PDF button.